Matrix metalloproteinases (MMPs) in oral diseases

Oral Diseases

Volumn 10, Issue 6, 2004, Pages 311-318

  Sorsa, Timo ^a,b,c   Tjaderhane L ^a,b   Salo, T ^d,e  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c ORTON Invalid Foundation   (Finland)

^d UNIVERSITY OF OULU   (Finland)

^e OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Caries; Matrix metalloproteinases; Oral; Periodontitis cancer

Indexed keywords

COLLAGENASE; MATRIX METALLOPROTEINASE; NEUTROPHIL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

DEMINERALIZATION; DENTAL CARIES; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME RELEASE; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATORY DISEASE; METASTASIS; MOUTH CANCER; MOUTH DISEASE; PATHOGENESIS; PERIODONTITIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; REVIEW; TISSUE INJURY; TOOTH PULP; TUMOR GROWTH;

COLLAGENASES; DENTAL CARIES; ENZYME ACTIVATION; HUMANS; MATRIX METALLOPROTEINASES; MOUTH NEOPLASMS; PERIODONTITIS;

EID: 9444232274     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2004.01038.x     Document Type: Review

References (73)

1. Apajalahti S, Sorsa T, Railavuo S et al (2003). The in vivo levels of matrix metlloproteinase-1 and -8 in gingival crevicular fluid during initial orthodontic tooth movement. J Dent Res 82: 1017-1021.
2. Agarwal D, Goodison S, Nicholson B et al (2003). Expression of MMP-8 and TYRP-1 correlates with the absence of metastasis in an isogenic human breast cancer model. Differentiation 71: 114-125.
3. Balbin M, Fueyo A, Tester AM et al (2003). Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat Genet 35: 252-257.
4. Bannikov GA, Karelina TV, Collier IE, Manner BL, Goldberg GI (2002). Substrate binding of gelatinase B induces its enzymatic activity in the presence of intact propeptide. J Biol Chem 277: 16022-16027.
5. Brew K, Dinakarpandian D, Nagase H (2000). Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477: 267-283.
6. Carrilho MRO, Tay FR, Pashley DH et al (2004). Mechanical stability of resin-dentin bond components. Dent Mater (in press).
7. Cianfrocca M, Cooley TP, Lee JY (2002). Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study. Clin Oncol 20: 153-159.
8. Coussens LM, Fingleton B (2002). Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295: 2387-2392.
9. Curran S, Murray GI (1999). Matrix metalloproteinases in tumour invasion and metastasis. J Pathol 189: 300-308.
10. Eley BM, Cox SW (1998). Advances in periodontal diagnosis. 8. Commercial diagnostic kits based on GCF proteolytic and hydrolytic enzyme levels. Br Dent J 184: 373-376.
11. Emingil G, Atilla G, Sorsa T et al (2004a). The effect of adjunctive low-dose doxycyline therapy on clinical parameters and gingival crevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis. J Peridontol (in press).
12. Emingil G, Atilla G, Sorsa T et al (2004b). Effectiveness of adjunctive low-dose doxycyline therapy on clinical parameters and gingival crevicular fluid laminin-5γ2 chain levels in chronic adult periodontitis. J Periodontol (in press).
13. Fedarko NS, Jain A, Karadag A, Fisher LW (2004). Three small integrin-binding ligand N-linked glycoproteins (SIBLINGs) bind and activate specific matrix metalloproteinases. FASEB J (electronic publication ahead of print).
14. Fullmer HM, Gibson W (1966). Collagenolytic activity in gingivae of man. Nature 209: 728-729.
15. Golub LM, Lee HM, Ryan ME et al (1998). Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res 12: 12-26.
16. Gross J, Lapiere CM (1962). Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci 48: 1014-1022.
17. Hanemaaijer R, Sorsa T, Konttinen YT et al (1997). Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. J Biol Chem 272: 31504-31509.
18. Hashimoto M, Ohno H, Sano H et al (2002). Micromorphological changes in resin-dentin bonds after 1 year of water storage. J Biomed Mater Res 63: 306-311.
19. Hashimoto M, Ohno H, Sano H et al (2003a). Degradation patterns of different adhesives and bonding procedures. J Biomed Mater Res 66B: 324-330.
20. Hashimoto M, Tay FR, Ohno H et al (2003b). SEM and TEM analysis of water degradation of human dentinal collagen. J Biomed Mater Res 66B: 287-298.
21. Hashimoto M, Ito S, Carvalho RM et al (2004). Collagenolytic activity in dentin: effects of bonding procedures (abstract). The IADR/AADR/CADR 82nd General Session (March 10-13, 2004), Honolulu, HI, USA (http://iadr.confex.com/ iadr/2004Hawaii/techprogram/index.html).
22. Heikkilä P, Teronen O, Moilanen M et al (2002). Bisphosphonates inhibit stromelysin-1 (MMP-3), matrix metalloelastase (MMP-12), collagenase-3 (MMP-13) and enamelysin (MMP-20), but not urokinase-type plasminogen activator, and diminish invasion and migration of human malignant and endothelial cell lines. Anti-Cancer Drugs 13: 245-254.
23. Hidalgo M, Eckhardt SG (2001). Development of matrix metalloproteinase inhibitors in cancer therapy. J Natl Cancer Inst 93: 178-193.
24. Holopainen J, Moilanen J, Sorsa T et al (2003). Activation of matrix metalloproteinase-8 by membrane-type 1-MMP and their expression in human tears afetr photoreactive keratectomy. Invest Ophtalmol Vis Sci 44: 2550-2556.
25. Ingman T, Tervahartiala T, Ding Y et al (1996). Matrix metalloproteinasee and their inhibitors in gingival crevicular fluid nad saliva of periodontitis patients. J Clin Periodontol 23: 1127-1132.
26. Kiili M, Cox SW, Chen HW et al (2002). Collagenase-2 (MMP-8) and collagnase-3 (MMP-13) in adult periodontitis: molecular forms and levels in gingival crevicular fluid and immunolocalization in gingival tissue. J Clin Periodontol 29: 224-232.
27. Kivelä-Rajamäki M, Teronen O, Maisi P et al (2003a). Laminin-5 gamma2-chain and collgenase-2 (MMP-8) in human peri-implant sulcular fluid. Clin Oral Impl Res 14: 158-165.
28. Kivelä-Rajamäki M, Maisi P, Srinivas R et al (2003b). Levels and molecular forms of MMP-7 (matrilysin-1) and MMP-8 (collagenase-2) in diseased human peri-implant sulcular fluid (PISF). J Periodont Res 38: 583-590.
29. Koivunen E, Ristimäki A, Itkonen O et al (1991). Tumor-associated trypsin participates in cancer cell-mediated degradation of extracellular matrix. Cancer Res 51: 2107-2112.
30. Koivunen E, Arap W, Valtanen H et al (1999). Tumor targeting with a selective gelatinase inhibitor. Nature Biotechnol 17: 768-774.
31. Mäntylä P, Kinane DF, Tikanoja S et al (2003). Gingival crevicular fluid collagenase-2 (MMP-8) test strip for chain-side monitoring of periodontotis. J Periodont Res 38: 436-439.
32. Martin-De Las Heras S, Valenzuela A, Overall CM (2000). The matrix metalloproteinase gelatinase A in human dentine. Arch Oral Biol 45: 757-765.
33. Medina OP, Soderlund T, Laakkonen LJ et al (2001). Binding of novel peptide inhibitors of type IV collagenases to phospholipid membranes and use in liposome targeting to tumor cells in vitro. Cancer Res 61: 3978-3985.
34. Moilanen M, Pirilä E, Grenman R et al (2002). Expression and regulation of collagenase-2 (MMP-8) in head and neck squamous cell carcinomas. J Pathol 197: 72-81.
35. Moilanen M, Sorsa T, Stenman M et al (2003). Tumor-associated trypsinogen-2 (typsinogen-2) activates procollagenases (MMP-1, -8, -13) and stromelysin-1 (MMP-3) and degrades type I collagen. Biochemistry 42: 5414-5420.
36. Nagase H (1997). Activation mechanisms of matrix metalloproteinases. Biol Chem 378: 151-160.
37. Nyberg P, Moilanen M, Paju A et al (2002). MMP-9 activation by tumor trypsin-2 enhances in vivo invasion of human tongue carcinoma cells. J Dent Res 81: 831-835.
38. Nyberg P, Heikkilä P, Sorsa T et al (2003). Endostatin inhibits human tongue carcinoma cell invasion and intravasation and blocks the activation of matrix metalloprotease-2, -9 and -13. J Biol Chem 278: 22404-22410.
39. O'Reilly MS, Boehm T, Shing Y et al (1997). Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88: 277-285.
40. Overall CM, Lopez-Otin C (2002). Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2: 657-672.
41. Palosaari H, Wahlgren J, Larmas M et al (2000). The expression of MMP-8 in odontoblasts and dental pulp cells is down-regulated by TGF-beta. J Dent Res 79: 77-84.
42. Palosaari H, Ding Y, Larmas M et al (2002). Regulation and interactions of MT1-MMP and MMP-20 in human odontoblasts and pulp tissue in vitro. J Dent Res 81: 354-359.
43. Palosaari H, Pennington C, Larmas M et al (2003). Expression profile of MMPs and TIMPs in mature human odontoblasts and pulp tissue. Eur J Oral Sci 111: 117-127.
44. Pashley DH, Tay FR, Yiu C et al (2004). Collagen degradation by host-derived enzymes during aging. J Dent Res 83: 216-221.
45. Pei D, Weiss SJ (1995). Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 375: 244-247.
46. Prikk K, Maisi P, Reintam MA et al (2002). Airway obstruction correlates with collagenase-2 expression and activation in bronchial asthma. Lab Invest 82: 1535-1545.
47. Reddy MS, Geurs NC, Gunsolley JC (2003). Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents. A systematic review. Ann Periodontol 8: 12-37.
48. Salo T, Liotta LA, Keski-Oja J et al (1982). Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells - role in metastasis. Int J Cancer 30: 669-673.
49. Salo T, Liotta LA, Tryggvason K (1983). Purification and characterization of a murine basement membrane collagen degrading enzyme secreted by metastatic tumor cells. J Biol Chem 258: 3058-3063.
50. Salo T, Turpeenniemi-Hujanen T, Tryggvason K (1985). Tumor promoting phorbol esters and cell proliferation stimulate secretion of basement membrane (type IV) collagen-degrading metalloproteinase by human fibroblasts. J Biol Chem 260: 8526-8531.
51. Salo T, Mäkela M, Kylmäniemi M et al (1994). Expression of matrix metalloproteinase-2 and -9 during early human wound healing. Lab Invest 70: 176-182.
52. Sano H, Yoshikawa T, Pereira PN et al (1999). Long-term durability of dentin bonds made with a self-etching primer, in vivo. J Dent Res 78: 906-911.
53. Sorsa T, Uitto V-J, Suomalainen K et al (1987). A trypsin-like protease from Bacteroides gingivalis; partial purification and charaterization. J Periodont Res 22: 375-380.
54. Sorsa T, Uitto V-J, Suomalainen K et al (1988). Comparison of interstital collagenasese from human gingiva, sulcular fluid and polymorhonuclear leukocytes. J Periodont Res 23: 386-393.
55. Sorsa T, Ding Y, Ingman T et al (1995). Cellular source, activation and inhibition of dental plaque collagenase. J Clin Periodontol 22: 709-717.
56. Sorsa T, Salo T, Koivunen E et al (1997). Activation of type IV procollageases by human tumor-associated trypsin-2. J Biol Chem 272: 21067-21074.
57. Sorsa T, Mäntylä P, Rönkä H et al (1999). Scientific basis of a matrix metalloproteinase-8 specific chair-side test fror monitoring periodontal and peri-implant health and disease. Ann NY Acad Sci 878: 130-140.
58. Stenman U (2002). Tumor-associated trypsin inhibitor. Clin Chem 48: 1206-1209.
59. Stenman UH, Huhtala ML, Koistinen R et al (1982). Immunochemical demonstration of an ovarian cancer associated urinary peptide. Int J Cancer 30: 53-57.
60. Sulkala M, Sorsa T, Teronen O et al (2001). The effect of MMP inhibitor Metastat on fissure caries progression in rats. J Dent Res 80: 1545-1549.
61. Sulkala M, Larmas M, Sorsa T et al (2002). The localization of matrix metalloproteinase-20 (MMP-20, enamelysin) in mature human teeth. J Dent Res 81: 603-607.
62. Sutinen M, Kainulainen T, Hurskainen T et al (1998). Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis. Br J Cancer 77: 2239-2245.
63. Tervahartiala T, Pirilä E, Ceponis A et al (2000). The in vivo expression of collagenolytic matrix metalloproteinases (MMP-2,-8,-13 and -14) and matrilysin-1 (MMP-7) in adult and juvenile periodontitis. J Dent Res 79: 1969-1977.
64. Thomas GT, Lewis MO, Speight PM (1999). Matrix metalloproteinases and oral cancer. Oral Oncol 35: 227-233.
65. Tjäderhane L, Salo T, Larjava H et al (1998a). A novel organ culture method of human odontoblasts in vitro: gelatinase expression by odontoblasts is differentially regulated by TGF-beta1. J Dent Res 77: 1486-1496.
66. Tjäderhane L, Larjava H, Sorsa T et al (1998b). The activation and function of host matrix metalloproteinases in dentin matrix breakdown in caries lesions. J Dent Res 77: 1622-1629.
67. Tjäderhane L, Palosaari H, Wahlgren J et al (2001). Human odontoblast culture method: the expression of collagen and matrix metalloproteinases (MMPs). Adv Dent Res 15: 55-58.
68. Uitto V-J, Overall CM, McCulloch C (2003). Proteolytic host enzymes in gingival crevice fluid. Periodontology 2000 31:77-104.
69. Väänänen A, Srinivas R, Parikka M et al (2001). Expression and regulation of MMP-20 in human tongue carcinoma cells. J Dent Res 80: 1884-1889.
70. Van den Steen PE, Dubois B, Nelissen I et al (2002). Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol 37: 375-536.
71. Wahlgren J, Maisi P, Sorsa T et al (2001). Expression and induction of collagenases (MMP-8 and -13) in plasma cells. J Pathol 194: 217-224.
72. Wahlgren J, Salo T, Teronen O et al (2002). Matrix metalloproteinase-8 (MMP-8) in pulpal and periapical inflammation and periapical root-canal exudates. Int Endod J 35: 897-904.
73. Yorioka CW, Coletta RD, Alves F et al (2002). Matrix metalloproteinase-2 and -9 activities correlate with the disease-free survival of oral squamous cell carcinoma patients. Int J Oncol 20: 189-194.